You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

1-Methylnicotinamide

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, Fatigue Syndrome, Chronic Trial in Lódz (1-MNA)

Completed
  • Covid19
  • Fatigue Syndrome, Chronic
  • 1-MNA
  • Łódź, Poland
    Medical Center, Saint Family Hospital
Jul 14, 2021

Hypertriglyceridemia Trial in Montreal (1-Methylnicotinamide (1-MNA), Placebo)

Completed
  • Hypertriglyceridemia
  • 1-Methylnicotinamide (1-MNA)
  • Placebo
  • Montreal, Quebec, Canada
    Institut de Cardiologie de Montreal
Feb 20, 2020

Covid19, Stage 1 Acute Kidney Injury Trial in Boston (MIB-626, Placebo, Home Treatment)

Recruiting
  • Covid19
  • Stage 1 Acute Kidney Injury
  • Boston, Massachusetts
    The Brigham and Women's Hospital
Nov 29, 2021

Healthy Trial in Poznan (Cardio-pulmonary exercise test)

Completed
  • Healthy
  • Cardio-pulmonary exercise test
  • Poznań, Poland
    Poznan University of Physical Education
Nov 10, 2021

Interaction, Endogenous Biomarkers Trial in Spokane (MetFORMIN Oral Solution, Cimetidine 400 MG, Furosemide Oral Liquid Product)

Recruiting
  • Interaction
  • Endogenous Biomarkers
  • MetFORMIN Oral Solution
  • +3 more
  • Spokane, Washington
    Washington State University College of Pharmacy and Pharmaceutic
Sep 8, 2022

Bone Metastasis, Malignant Hemopathy Trial in Saint-Priest en Jarez, Villejuif (blood and urines samples)

Terminated
  • Bone Metastasis
  • Malignant Hemopathy
  • blood and urines samples
  • Saint-Priest en Jarez, France
  • +1 more
Feb 4, 2022

Cognitive Performance Trial in Bergen (Seafood, Non-seafood)

Completed
  • Cognitive Performance
  • Seafood
  • Non-seafood
  • Bergen, Norway
    NIFES
Nov 23, 2020

Chronic Kidney Diseases, Deficiency, Vitamin D Trial in Aurora, Pittsburgh (Cholecalciferol)

Completed
  • Chronic Kidney Diseases
  • Deficiency, Vitamin D
  • Cholecalciferol
  • Aurora, Colorado
  • +1 more
Jun 29, 2021

Healthy Trial in Brussels (Metformin, PF-04965842)

Completed
Has Results
  • Healthy
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Jan 22, 2020

Healthy Adults, High Altitude, Isolation, Social Trial in Erfurt (Human milk oligosaccharides, Maltose)

Enrolling by invitation
  • Healthy Adults
  • +2 more
  • Human milk oligosaccharides
  • Maltose
  • Erfurt, Germany
    IU International University of Applied Sciences
Nov 9, 2023

Micronutrient Status Trial (Micronutrient Supplement)

Not yet recruiting
  • Micronutrient Status
  • Micronutrient Supplement
  • (no location specified)
Oct 9, 2023

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

COVID-19 Trial in Thái Bình (COVIVAC vaccine)

Completed
  • COVID-19
  • COVIVAC vaccine
  • Thái Bình, Thai Binh, Vietnam
    District Health Center of Vu Thu District
Jul 12, 2023

Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)

Completed
  • Ankylosing Spondylitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 10, 2023

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of

Not yet recruiting
  • Meningococcal Meningitis
  • batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
  • +3 more
  • Surabaya, Indonesia
    Husada Utama Hospital
Nov 13, 2023

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Atopic Dermatitis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Jianzhong Zhang
Oct 10, 2023

Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)

Not yet recruiting
  • Hypertension,Essential
  • Songling Xuemaikang Capsules
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Oct 17, 2023

Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)

Not yet recruiting
  • Diabetes
  • INS062 injection、INS068 injection、HR20014 injection
  • (no location specified)
May 24, 2023

COVID-19 Trial (STI-1558)

Not yet recruiting
  • COVID-19
  • (no location specified)
Sep 15, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 22, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )

Recruiting
  • Type1diabetes
  • +2 more
  • Infusion of GIP[1-42], GIP[1-30] or placebo
  • Hellerup, Copenhagen, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 13, 2023